Magnetic resonance imaging performed with gadoxetate disodium for the diagnosis of hepatocellular carcinoma in cirrhotic and non-cirrhotic patients

An Tang; Matthew Mcinnes; Thomas A. Hope; Kim Nhien Vu; Devendra Amre; Tanya Wolfson; Chantal Roy; Benoît R. Mâsse; Claude Sirlin

doi:10.1002/14651858.CD012766

Magnetic resonance imaging performed with gadoxetate disodium for the diagnosis of hepatocellular carcinoma in cirrhotic and non-cirrhotic patients

An Tang, Matthew Mcinnes, Thomas A. Hope, Kim Nhien Vu, Devendra Amre, Tanya Wolfson, Chantal Roy, Benoît R. Mâsse, Claude Sirlin

School of Medicine

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

This is a protocol for a Cochrane Review (Diagnostic test accuracy). The objectives are as follows: To determine the per-lesion and per-person diagnostic accuracy of magnetic resonance imaging (MRI) performed with gadoxetate disodium for the diagnosis of HCC in people with chronic liver disease. To identify factors that influence the reported diagnostic performance of hepatobiliary contrast agents.

Original language	English (US)
Article number	CD012766
Journal	Cochrane Database of Systematic Reviews
Volume	2017
Issue number	8
DOIs	https://doi.org/10.1002/14651858.CD012766
State	Published - Aug 21 2017

ASJC Scopus subject areas

Pharmacology (medical)

Access to Document

10.1002/14651858.CD012766

Cite this

Tang, A., Mcinnes, M., Hope, T. A., Vu, K. N., Amre, D., Wolfson, T., Roy, C., Mâsse, B. R., & Sirlin, C. (2017). Magnetic resonance imaging performed with gadoxetate disodium for the diagnosis of hepatocellular carcinoma in cirrhotic and non-cirrhotic patients. Cochrane Database of Systematic Reviews, 2017(8), Article CD012766. https://doi.org/10.1002/14651858.CD012766

@article{1ab875740a744a87baeb61cc86fdbc1e,

title = "Magnetic resonance imaging performed with gadoxetate disodium for the diagnosis of hepatocellular carcinoma in cirrhotic and non-cirrhotic patients",

abstract = "This is a protocol for a Cochrane Review (Diagnostic test accuracy). The objectives are as follows: To determine the per-lesion and per-person diagnostic accuracy of magnetic resonance imaging (MRI) performed with gadoxetate disodium for the diagnosis of HCC in people with chronic liver disease. To identify factors that influence the reported diagnostic performance of hepatobiliary contrast agents.",

author = "An Tang and Matthew Mcinnes and Hope, {Thomas A.} and Vu, {Kim Nhien} and Devendra Amre and Tanya Wolfson and Chantal Roy and M{\^a}sse, {Beno{\^i}t R.} and Claude Sirlin",

note = "Publisher Copyright: {\textcopyright} 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.",

year = "2017",

month = aug,

day = "21",

doi = "10.1002/14651858.CD012766",

language = "English (US)",

volume = "2017",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "John Wiley and Sons Ltd",

number = "8",

}

TY - JOUR

T1 - Magnetic resonance imaging performed with gadoxetate disodium for the diagnosis of hepatocellular carcinoma in cirrhotic and non-cirrhotic patients

AU - Tang, An

AU - Mcinnes, Matthew

AU - Hope, Thomas A.

AU - Vu, Kim Nhien

AU - Amre, Devendra

AU - Wolfson, Tanya

AU - Roy, Chantal

AU - Mâsse, Benoît R.

AU - Sirlin, Claude

PY - 2017/8/21

Y1 - 2017/8/21

N2 - This is a protocol for a Cochrane Review (Diagnostic test accuracy). The objectives are as follows: To determine the per-lesion and per-person diagnostic accuracy of magnetic resonance imaging (MRI) performed with gadoxetate disodium for the diagnosis of HCC in people with chronic liver disease. To identify factors that influence the reported diagnostic performance of hepatobiliary contrast agents.

AB - This is a protocol for a Cochrane Review (Diagnostic test accuracy). The objectives are as follows: To determine the per-lesion and per-person diagnostic accuracy of magnetic resonance imaging (MRI) performed with gadoxetate disodium for the diagnosis of HCC in people with chronic liver disease. To identify factors that influence the reported diagnostic performance of hepatobiliary contrast agents.

UR - http://www.scopus.com/inward/record.url?scp=85027723118&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027723118&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD012766

DO - 10.1002/14651858.CD012766

M3 - Article

AN - SCOPUS:85027723118

SN - 1465-1858

VL - 2017

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 8

M1 - CD012766

ER -

Magnetic resonance imaging performed with gadoxetate disodium for the diagnosis of hepatocellular carcinoma in cirrhotic and non-cirrhotic patients

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this